Algert Global’s Arcus Biosciences RCUS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Sell |
77,656
-191,376
| -71% | -$1.56M | 0.01% | 889 |
|
|
2025
Q1 | $2.11M | Buy |
269,032
+88,910
| +49% | +$698K | 0.05% | 585 |
|
|
2024
Q4 | $2.68M | Buy |
180,122
+67,275
| +60% | +$1M | 0.06% | 508 |
|
|
2024
Q3 | $1.73M | Buy |
112,847
+36,590
| +48% | +$559K | 0.05% | 609 |
|
|
2024
Q2 | $1.16M | Buy |
76,257
+17,999
| +31% | +$274K | 0.04% | 644 |
|
|
2024
Q1 | $1.1M | Sell |
58,258
-22,790
| -28% | -$430K | 0.04% | 590 |
|
|
2023
Q4 | $1.55M | Buy |
81,048
+9,030
| +13% | +$172K | 0.06% | 494 |
|
|
2023
Q3 | $1.29M | Buy |
72,018
+9,830
| +16% | +$176K | 0.06% | 507 |
|
|
2023
Q2 | $1.26M | Sell |
62,188
-53,901
| -46% | -$1.09M | 0.06% | 571 |
|
|
2023
Q1 | $2.12M | Buy |
116,089
+102,706
| +767% | +$1.87M | 0.1% | 325 |
|
|
2022
Q4 | $277K | Sell |
13,383
-22,910
| -63% | -$474K | 0.02% | 945 |
|
|
2022
Q3 | $949K | Buy |
36,293
+13,603
| +60% | +$356K | 0.06% | 570 |
|
|
2022
Q2 | $575K | Buy |
+22,690
| New | +$575K | 0.04% | 707 |
|
|
2020
Q2 | – | Sell |
-25,378
| Closed | -$352K | – | 489 |
|
|
2020
Q1 | $352K | Sell |
25,378
-76,468
| -75% | -$1.06M | 0.15% | 220 |
|
|
2019
Q4 | $1.03M | Buy |
101,846
+86,176
| +550% | +$871K | 0.31% | 117 |
|
|
2019
Q3 | $143K | Buy |
+15,670
| New | +$143K | 0.05% | 301 |
|